Protocadherin-19 is essential for early steps in brain morphogenesis  by Emond, Michelle R. et al.
Developmental Biology 334 (2009) 72–83
Contents lists available at ScienceDirect
Developmental Biology
j ourna l homepage: www.e lsev ie r.com/deve lopmenta lb io logyProtocadherin-19 is essential for early steps in brain morphogenesis
Michelle R. Emond, Sayantanee Biswas, James D. Jontes ⁎
Center for Molecular Neurobiology and Department of Neuroscience, 115 Rightmire Hall, 1060 Carmack Road, Ohio State University, Columbus, OH 43210, USA⁎ Corresponding author. Fax: +1 614 292 5379.
E-mail address: jontes.1@osu.edu (J.D. Jontes).
0012-1606/$ – see front matter © 2009 Elsevier Inc. Al
doi:10.1016/j.ydbio.2009.07.008a b s t r a c ta r t i c l e i n f oArticle history:
Received for publication 21 February 2009
Revised 2 July 2009
Accepted 8 July 2009






ConvergenceOne of the earliest stages of brain morphogenesis is the establishment of the neural tube during neurulation.
While some of the cellular mechanisms responsible for neurulation have been described in a number of
vertebrate species, the underlying molecular processes are not fully understood. We have identiﬁed the
zebraﬁsh homolog of protocadherin-19, a member of the cadherin superfamily, which is expressed in the
anterior neural plate and is required for brain morphogenesis. Interference with Protocadherin-19 function
with antisense morpholino oligonucleotides leads to a severe disruption in early brain morphogenesis.
Despite these pronounced effects on neurulation, axial patterning of the neural tube appears normal, as
assessed by in situ hybridization for otx2, pax2.1 and krox20. Characterization of embryos early in
development by in vivo 2-photon timelapse microscopy reveals that the observed disruption of
morphogenesis results from an arrest of cell convergence in the anterior neural plate. These results provide
the ﬁrst functional data for protocadherin-19, demonstrating an essential role in early brain development.
© 2009 Elsevier Inc. All rights reserved.Introduction
One of the ﬁrst steps in brain morphogenesis is neurulation, the
process that forms the neural tube from the neural plate (Copp et al.,
2003; Schoenwolf and Smith, 1990; Schoenwolf and Smith, 2000). In
zebraﬁsh, neurulation involves the convergence of neuroectodermal
cells toward the dorsal midline to form the neural keel; this thickened
rod of cells then cavitates to form the neural tube (Lowery and Sive,
2004; Papan and Campos-Ortega, 1994; Schmitz et al., 1993). Several
genes have been identiﬁed that affect this process in zebraﬁsh,
including members of the non-canonical Wnt signaling pathway
(Ciruna et al., 2006; Tawk et al., 2007), as well as the cell adhesion
molecule, N-cadherin (Lele et al., 2002; Masai et al., 2003). However,
despite the progress that has beenmade, the underlyingmolecular and
cellular mechanisms of neurulation remain incompletely understood.
Protocadherins (pcdhs) were ﬁrst discovered by degenerate PCR in
a search for additional members of the classical cadherin family of
calcium-dependent cell adhesion molecules (Sano et al., 1993).
Subsequently, the number of identiﬁed protocadherin protein pro-
ducts in vertebrates has grown substantially, making this the largest
subfamily within the cadherin superfamily (Nollet et al., 2000). Most
of these can be organized into four subfamilies: α-, β-, γ- and δ-
protocadherins. The δ-protocadherins can further be divided into δ1
and δ2 subgroups (Redies et al., 2005; Vanhalst et al., 2005;Wolverton
and Lalande, 2001). Although they comprise a large group of genesl rights reserved.conserved throughout vertebrate evolution, the cellular roles of most
protocadherins have not yet been determined.
Several of the δ-protocadherins have been shown to play roles in
early development. Both Pcdh8/PAPC and Pcdh10 are involved in
convergent extension and somitogenesis (Kim et al., 2000; Kim et al.,
1998; Murakami et al., 2006; Schambony and Wedlich, 2007;
Unterseher et al., 2004; Yamamoto et al., 1998), while Pcdh18a has
been implicated in cell movements during epiboly (Aamar and Dawid,
2008). Other evidence also implicates the protocadherins as having
roles in controlling cell movement. Pcdh18 has been shown to interact
with Disabled-1 (Homayouni et al., 2001), an element in the Reelin
signaling pathway that mediates neuronal migration. In addition,
Pcdh10 interacts with the actin binding protein Nap-1 and can
regulate contact-dependent motility in vitro (Nakao et al., 2008).
Protocadherin-19 (pcdh19) is a member of the non-clustered δ2-
protocadherin family (Wolverton and Lalande, 2001), which has been
shown to be expressed thoughout the central nervous system in
mammals (Gaitan andBouchard, 2006; Kimet al., 2007). Recently, it has
been demonstrated thatmutations in human pcdh19 are responsible for
an X-linked, female-limited form of epilepsy and mental retardation
(Depienne et al., 2009; Dibbens et al., 2008). Affected females suffer
early onset of seizures (6–36 months) and exhibit cognitive impair-
ment, as well as other disorders, including autism, obsessive–compul-
sive disorder, schizophrenia and aggressive behavior (Dibbens et al.,
2008; Ryan et al.,1997; Scheffer et al., 2008).Mutations from16 families
were mapped to Xq22 and, subsequently, each was found to harbor
mutations in pcdh19 (Depienne et al., 2009; Dibbens et al., 2008).
In this study, we provide the ﬁrst characterization of pcdh19
function during development. We show that pcdh19 is essential for
early stages of neurulation in the anterior neural plate of the zebraﬁsh
73M.R. Emond et al. / Developmental Biology 334 (2009) 72–83embryo, as interference with pcdh19 function blocks convergence cell
movements and disturbs brain morphogenesis. This phenotype is
speciﬁc to future brain regions, as neurulation in the spinal cord
appears unaffected. In contrast to other mutants and morphants
exhibiting delayed cell convergence in the neural plate (Tawk et al.,
2007), the convergence defects observed in pcdh19morphants do not
result in a duplicated neural tube axis.
Materials and methods
Fish maintenance
Adult zebraﬁsh (Danio rerio) and embryos of the Tübingen longﬁn
and AB⁎ strains were maintained at ~28.5 °C and staged according to
Westerﬁeld (1995). Embryos were raised in E3 embryo medium
(Westerﬁeld, 1995) with 0.003% phenylthiourea (Sigma-Aldrich) to
inhibit pigment formation. The transgenic line Tg(h2afz:GFP)kca66/+
was obtained from the Zebraﬁsh International Resource Center.
Cloning of pcdh19
Degenerate PCRwas performed using the following primers: primer
1, 5′-AARSSNNTNGAYTRYGA-3′ and primer 2, 5′-NNNGGNGCRTTRTC-
RTT-3′ (Sano et al., 1993). A 130 bp fragment was obtained that
exhibited sequence similarity to protocadherin genes. This fragment
wasDIG-labeled byPCR andused as a probe in a hybridization screen of
a 15–19 hpf zebraﬁsh cDNA library (constructed by B. Appel and kindly
provided by J. Eisen). One full-length clone was obtained that
contained a 3252 bp open reading frame. BLAST searches using tblastn
showed that the clone was homologous to mammalian pcdh19.
Phylogenetic analysis was performed using a CLUSTALW multiple
sequence alignment server (http://align.genome.jp).
Characterization of pcdh19 expression
To characterize the temporal expression of Pcdh19, RT-PCR was
used to amplify a 1.1 kb portion of the cytoplasmic domain. Brieﬂy,
total RNAwas isolated from embryos ranging from 4.5 to 120 hpf using
Trizol (Invitrogen). First strand synthesis was performed using
SuperScript III reverse transcriptase (Invitrogen) to generate cDNA,
which was used as template for PCR (Platinum Taq Polymerase High
Fidelity, Invitrogen). Primers for β-actin were used as a control for
each developmental stage, as was a reaction lacking reverse
transcriptase. Two bands were detected, which were cloned and
sequenced to verify alternative splicing. In situ hybridization was
performed using standard methods (Westerﬁeld, 1995). Antisense
riboprobe, generated against the cytoplasmic domain of Pcdh19, was
labeled with DIG-dUTP (Roche) and added to a ﬁnal concentration of
400 ng/ml. AP-conjugated anti-DIG Fab fragments (Roche) were used
at 1:5000, and the in situswere developed with NBT/BCIP (Roche). In
addition, the following probes were also used: foxd3 (Odenthal and
Nusslein-Volhard, 1998), pax2.1 (Krauss et al., 1991), krox20 (Wilk-
inson et al., 1989), otx2 (Macdonald et al., 1994) and myod (Weinberg
et al., 1996).
Cryosectioning
For cryosectioning, embryos were soaked in 30% sucrose in PBS
overnight. They were then embedded in O.C.T (Ted Pella Inc.) and
sectioned at 20 μm. The sections were placed on gelatin-coated slides,
washed in PBS and mounted in 1:1 PBS: glycerol solution.
Generation of polyclonal Pcdh19CD antibody
Antibodies were produced against the cytoplasmic domain of
zebraﬁsh Pcdh19. Rabbits were immunized against a GST-fusionprotein and afﬁnity puriﬁcation was performed using an MBP-fusion
(Covance Research Products).
COS cell culture, transfection, and immunostaining
COS cells were maintained in DMEM supplemented with 10% FBS
and penicillin–streptomycin at 37 °C in 5% CO2. One day before
transfection, cells were split and plated at 2×105 cells per well in a 24-
well plate. Transfections were performed using Lipofectamine 2000
and carried out according to the manufacturer's instructions (Invitro-
gen). Cells were transiently transfected with CMV∷Pcdh19-GFP. 24 h
after transfection, cells were ﬁxed in 4% paraformaldehyde in PBS,
permeabilized in PBS+0.25% Triton X-100, and blocked in PBS+3%
BSA+2% NGS. The Pcdh19-CD antibody was used at a dilution of
1:250. Anti-rabbit-rhodamine secondary antibodies (Jackson Immu-
noResearch) were used at 1:500. DAPI was added at a concentration of
100 ng/mL. Coverslips were mounted in Fluoromount G (Electron
Microscopy Sciences) and imaged on a Zeiss Axiostarmicroscope (Carl
Zeiss Microimaging).
Western blot analysis
Proteins were extracted from 14 somite stage embryos using
homogenization buffer (50 mM Tris–HCl pH 6.8, 10% SDS, 10 mM
EDTA, Mini Complete EDTA-free Protease inhibitor cocktail (Roche
Applied Science). Extracts were boiled for 10 min, microcentrifuged at
4 °C for 10 min, and the supernatant reserved. Protein concentration
was determined using the BCA assay (Pierce). Sample buffer was
added to the extracts, which were then heated to 70 °C for 10min, and
50 μg/ml total protein/lanewas loaded onto 10% Bis–Tris NuPAGE gels
(Invitrogen). Proteins were transferred (Bio-Rad) onto nitrocellulose
membranes (GE Healthcare), blocked in TBST+7% nonfat milk, and
incubated in block with Pcdh19-CD antibody at 1:800, or β-actin
antibody at 1:1000 (Developmental Studies Hybridoma Bank). An
anti-rabbit-HRP secondary antibody (Jackson ImmunoResearch) was
used at 1:5000 and the chemiluminescent signal was ampliﬁed using
Western Lightning (Perkin Elmer). Blots were imaged on an Omega
12iC Molecular Imaging System (UltraLum, Inc.). For Western blotting
of COS cell extracts, cells were washed in PBS and lysed in TBS+1%
Triton X-100 24 h after transfection. Samples were subjected to SDS-
PAGE as described above.
Morpholino, DNA and mRNA injections
Antisense morpholino oligonucleotides were purchased from
Gene-Tools LLC. The morpholinos were dissolved in dH2O at ~8 ng/
nl, aliquoted and stored at−80 °C. For use, morpholinos were diluted
to aworking concentration of 2–4 ng/nl in dH2O and 1 nl was injected
into 1-cell stage embryos. Control 5-bp mismpatch morpholinos were
designed for both pcdh19 splice-blocking and translation-blocking
morpholinos. Efﬁcacy of morpholinos was conﬁrmed using RT-PCR
and Western blot, as described above.
Morpholinos used in this study were the following:
19Mo-T (translation-blocking): 5′ TCCTTGGAATGCATTGTACCTGT-
TGA 3′
19Mo-Tmis 5′ TTCTTCGAATGCATGGTATCTCTTGA 3′
19Mo-S1 (splice-blocking): 5′ AATTGTCTGGGTACCTGCAGTTGTA 3′
19Mo-S1mis 5′ AAATGTGTGCGTACCTCCAGTTCTA 3′
19Mo-S2 (splice-blocking): 5′ ACTCCGCCACCCTGCGCAGGTACAA 3′.
For the mRNA rescue experiments, we injected morpholino along
with 200 pg of mRNA encoding full-length Pcdh19, which was
inserted into pCS2+ and synthesized with an SP6 mMessage
mMachine kit (Ambion). For expression of Pcdh19 using
HSP70∷Pcdh19 plasmid, embryos were injected with 30 pg of DNA.
At 6 somite stage, embryos were heat-shocked at 37 °C for 1 h.
Fig. 1. Characterization of zebraﬁsh Protocadherin-19. (A) Schematic representation of the domain organization of Pcdh19. Pcdh19 is a type I transmembrane proteinwith an amino-
terminal signal sequence (S), 6 extracellular cadherin repeats (EC1–6), a single-pass transmembrane domain (T), and a large, carboxy-terminal cytoplasmic domain (CP). (B) Graph
of sequence identity between zebraﬁsh and human Pcdh19, plotted as a function of protein domain. A high degree of homology is exhibited throughout the protein, with the highest
percentage identity occurring in the transmembrane domain. (C) Phylogenetic comparison of Pcdh19 from nine species.
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A 100× stock solution (5 mM) of BODIPY-ceramide (Invitrogen)
was made up in DMSO, aliquoted and stored at−20 °C. A 1× working
solution of dye consisted of 10 mM HEPES, pH 7.6 and 50μM BODIPY-
ceramide in embryo medium. Embryos were soaked in the dye
overnight, from ~8–10 hpf, in the dark. The followingmorning, labeled
embryos were dechorionated and transferred to fresh embryo
medium. Embryos labeled with BODIPY-ceramide or transgenic
embryos, Tg(h2afz:GFP)kca66 expressing Histone H2A-GFP (Pauls et
al., 2001) were mounted in 1.5% lowmelting point agarose and placed
on a custom-built laser-scanning two-photon microscope. Excitation
was provided by a Chameleon-XR Ti:Sapphire laser (Coherent, Inc.),
tuned to 920 nm. We used a Zeiss Achroplan 20×/NA 0.5 objective
(Carl Zeiss Microimaging) for imaging. The software for control of theFig. 2. Genomic organization and alternative splicing of pcdh19. (A) The pcdh19 gene comp
domain, the transmembrane domain and a short segment of cytoplasmic domain are encod
RT-PCR reveals that expression of pcdh19 begins by 6 hpf and continues through developmen
band. There does not appear to be temporal variation in the expression of the two isoform
represents the full-length form of Pcdh19; we term this variant “isoform 1.” The shorter band
acids from the cytoplasmic domain; we refer to this variant as “isoform 2.”. E, Schematic remicroscope was very kindly provided by Dr. Noam Ziv (Technion,
Haifa, Israel). Images were scanned with a pixel size of 0.6 μm. For
long-term timelapse imaging, 20–25 optical sections were collected
(5 μm spacing) at 5 minute intervals for 6–24 h. Image processing was
performed using ImageJ (http://rsb.info.nih.gov/ij).
Results
Zebraﬁsh protocadherin-19 is a highly conserved member of the
cadherin superfamily
In a hybridization screen for zebraﬁsh protocadherins, we iden-
tiﬁed a full-length clone that contained a 3252 base pair open reading
frame, encoding a protein of 1083 residues and a predicted molecular
weight of ~120 kDa (Supplemental Fig. 1). As shown in Fig. 1A,rises 5 exons distributed over 85 kb of genomic sequence. (B) The entire extracellular
ed by exon 1. The remainder of the cytoplasmic domain is encoded by exons 2–5. (C)
t. In addition, we observe two splice variants: a larger, major band and a shorter minor
s. (D) Cloning and sequencing of the two PCR products reveals that the major band
represents the use of an alternative splice site, internal to exon 2, that deletes ~70 amino
presentation of the choice of alternative donor sites in exon 2.
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(residues 1–671), comprising a signal sequence and 6 amino-terminal
cadherin repeats, a single-pass transmembrane domain (residues
672–696) and an intracellular domain (residues 697–1083). TheFig. 3. Expression of pcdh19. (A–E) In situ hybridization of embryos labeled with pcdh19 ribo
somites (D) and 20 somites (E). Dorsal views are shown in A–E and lateral views are show
pcdh19 is expressed in the medial anterior neural plate. By 8 somite stage, pcdh19 expressi
eye primordia and additional bands present in the midbrain and hindbrain. These bands beco
more complex, with expression in the eye, hypothalamus, ventral midbrain and the tectum. In
In the trunk region, pcdh19 is expressed in cells along the midline. F–H, Cross-sections of em
somite stage (H). At 2 somite stage, pcdh19 is expressed medially in cells throughout the d
concentrated more ventrally in both the neural keel and neural rod. I–J, In situ hybridizations
brain regions are as follows: tel, telencephalon; di, diencephalon; mes, mesencephalon; cb, ce
three planes of section indicated in (J). Both the retina (ret) and the otic vesicle (ov) are l
(arrowheads) express high levels of pcdh19.extracellular domain contains 4 conserved cysteines, common to
several protocadherin family members, which have been shown to
contribute to the trafﬁcking and oligomerization of Pcdh8/PAPC in
Xenopus laevis (Chen et al., 2007). Zebraﬁsh Protocadherin-19 isprobe against cadherin repeats 1–3 at 75% epiboly (A), 2 somites (B), 8 somites (C), 14
n in A′–E′. Pcdh19 is expressed broadly and diffusely at 75% epiboly. At 2 somite stage,
on exhibits a banding pattern, with the anterior band encompassing the forebrain and
me sharper by 14 somite stage. By 20 somite stage, the pattern in the brain has become
addition, expression has become stronger andmore uniform throughout the hindbrain.
bryos labeled with pcdh19 riboprobe at 2 somite stage (F), 8 somite stage (G) and 14
orsoventral extent of the neural plate. As development proceeds, pcdh19 expression is
reveal more distinctive expression patterns at 30 hpf (I) and 48 hpf (J). Abbreviations of
rebellum; hb, hindbrain; tec, optic tectum. K–M, Cross-sections of 48 hpf embryos at the
abeled with the pcdh19 riboprobe. Notably, the neuroepithelia that line the ventricles
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Fig. 1); the sequence identity is better than 70% across the entire
protein (Fig. 1B), which is comparable to the degree of sequence
identity for other known homologs (71% for N-cadherin, 52% for E-
cadherin).
The cytoplasmic domain of Pcdh19 is relatively large and is highly
conserved. Analysis has not revealed the presence of any known
sequence motifs, and does not appear to align to any known protein
folds (data not shown). However, the cytoplasmic domain does have
sequence features that are conserved among other members of the δ-
protocadherin subfamily. These have previously been identiﬁed and
are termed CM1 (residues 858–886) and CM2 (residues 905–921).
Neither the function of these conserved sequences, nor the identity of
any putative binding partners, has yet been determined.
The pcdh19 gene consists of 5 exons spread over ~85 kb on
zebraﬁsh chromosome 14 (Fig. 2A). Like most other protocadherinFig. 4. Protocadherin-19 is required for brain morphogenesis. (A) Antisense morpholino oligo
two splice-blocking (Mo-S1 andMo-S2) morpholinos. Diagnostic primers (arrows: F, R1 and
Injection of Mo-S1 into 1-cell zebraﬁsh embryos is predicted to result in the inclusion of intr
type embryos show a strong band with F/R2 (normally spliced transcripts) and a very faint P
F/R1 PCR product may result from isolated pre-mRNA. In contrast, morphant embryos exh
indicating a shift toward aberrantly spliced pcdh19 transcripts. (C)Western blots using an afﬁ
reduction in protein levels in extracts prepared frommorphant embryos (Mo-S1 andMo-T) c
injectedwithmRNA encoding Pcdh19 (Mo-T/mRNA) or an HSP70:Pcdh19 plasmid (Mo-T/HS
Shown here are lateral views of wild type (D) or morphant (D′) embryos at 30 hpf. In morpha
and midbrain are compressed anteriorly within the head. Red lines indicate the approximate
have been labeled with the vital dye, BODIPY-ceramide. Images are single optical sections
midbrain and hindbrain ventricles and a characteristic constriction at the MHB (red arrows
ectopic folds and cell masses and appears compressed, and contact between lateral halvesgenes, the entire extracellular domain, the transmembrane domain
and a short cytoplasmic segment are encoded by a large, ﬁrst exon.
The remaining exons encode the bulk of the cytoplasmic domain
(Fig. 2B). Analysis of pcdh19 expression using RT-PCR reveals the
presence of two splice variants (Figs. 2C, D). The isoforms do not
appear to be developmentally regulated, as they are co-expressed
throughout development (Fig. 2B). The choice of the internal splice
site (isoform 2) results in the loss of 70 amino acids from the
cytoplasmic domain (Figs. 2D, E).
Protocadherin-19 is strongly expressed in the developing zebraﬁsh
nervous system
Labeled riboprobes directed against either the cytoplasmic domain
or cadherin repeats 1–3 were generated and used to perform in situ
hybridizations. Identical results were obtained with both probes, andnucleotides were designed against pcdh19, including a translation-blocking (Mo-T) and
R2) are shown. (B) Diagnostic RT-PCR was used to conﬁrm the predicted effect of Mo-S1.
on 1 and a premature stop codon just downstream of the exon 1 splice-donor site. Wild
CR product with F/R1, (unspliced or aberrantly spliced transcripts). The small amount of
ibit a strong band using the F/R1 primer set and reduced levels of F/R2 PCR product,
nity-puriﬁed rabbit polyclonal antibody against the Pcdh19 cytoplasmic domain shows a
ompared to uninjected embryos (WT), and a recovery of Pcdh19 levels in morphants co-
P). (D) Injection of Mo-S1 results in embryos with severely disrupted brainmorphology.
nts, the hindbrain is bumpy, the MHB (red arrows) appears misfolded and the forebrain
plane of section of the images shown in E and E′. (E) Dorsal views of live embryos that
. Wild type embryos (D) exhibit a symmetrically folded neural tube, with expanded
). In contrast, the brain of morphant embryos appears misfolded (E′): the forebrain has
of the alar plate is not maintained at the midline of the MHB (red arrows).
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epiboly, pcdh19 is expressed weakly and broadly in the embryo
(Fig. 3A). By early stages of neurulation (2 somite stage), expression of
pcdh19 is strong near the midline in the anterior neural plate and
present diffusely in more caudal regions of the neural plate (Fig. 3B).
As development proceeds, pcdh19 is expressed in the anterior neural
keel in a series of 4 axial domains, as well as along the ventral midline
of the trunk and in the tail bud (Figs. 3C, D). Expression becomesmore
pronounced at late keel stages, and is strongest in the forebrain and
optic primordia, as well as the hindbrain (Fig. 3D). By 20 hpf, pcdh19
becomes expressed more broadly in the hindbrain, as well as discrete
patches in the tectum and tegmentum (Fig. 3E). Expression is also
observed along the midline of the spinal cord (Fig. 3E′). Sections of
embryos at 2 somite stage show that pcdh19 expression is concen-
trated near the midline (Fig. 3F). At the neural keel (Fig. 3G) and
neural rod stages (Fig. 3H), pcdh19 expression appears more ventrally,
consistent with its early enrichment in the medial neural plate. In 1
dpf embryos, pcdh19 is expressed thoughout the brain and is par-
ticularly prevalent in the hindbrain and ventral midbrain (Fig. 3I). By
2 dpf, pcdh19 has evolved into a more complex pattern throughout
the forebrain and midbrain (Figs. 3J, K), as well as in the inner retina
(Fig. 3K). Interestingly, pcdh19 expression appears to be enriched in
the cell layers lining the ventricles (Figs. 3L, M).
Antisense morpholino knockdown of Protocadherin-19 disrupts brain
morphogenesis
To perform loss-of-function experiments of pcdh19 during zebra-
ﬁsh development, we designed antisense morpholino oligonucleo-
tides against pcdh19 (Fig. 4A), including a translation-blocking
morpholino (Mo-T) and two splice-blocking morpholino (Mo-S1
and Mo-S2). The splice-blocking morpholino, Mo-S1, targets the
splice-donor site of exon 1, which results in the inclusion of intron 1
and the introduction of a premature stop codon shortly after the
transmembrane domain. The splice-blocking morpholino, Mo-S2,
targets the splice-acceptor site of exon 2, resulting in deletion of
exon 2 and a premature stop codon shortly after exon 1. In order to test
for the predicted effects, we performed RT-PCR on embryos injected
with Mo-S1 (Fig. 4B). Compared to wild type embryos, there was an
increase in the amount of transcript that contained intron 1, and a
decrease in the amount of properly spliced mRNA. Cloning andFig. 5. Characterization of pcdh19 morpholino speciﬁcity. (A) The pcdh19 morphant phenot
increasing doses of Mo-S1 result in a shift towardmore severe phenotypes. (B) Three differen
(Mo-S1, 2.5 ng; Mo-S2, 4 ng), yield comparable phenotypes. In contrast, 5 base pair mismatc
Co-injection of subthreshold doses of Mo-S1 and Mo-T (1 ng of each) results in a robust phen
injection of 200 ng of pcdh19 capped mRNA partially rescues the effects of 1.5 ng Mo-T, shifsequencing of the aberrant PCR product conﬁrmed the inclusion of
intron 1 in the transcripts (data not shown). We generated an afﬁnity-
puriﬁed rabbit polyclonal antibody against the cytoplasmic domain of
Pcdh19. While this antibody has proven unsuitable for immunocy-
tochemistry in zebraﬁsh (either wholemount or on cryosections), it
recognizes Pcdh19 prepared from embryo extracts, as well as in
cultured cells transfected with zebraﬁsh Pcdh19-GFP (Supplemental
Fig. 2). Extracts prepared frommorphant embryos exhibit a reduction
in Pcdh19 on Western blots relative to wild type embryos, while
Pcdh19 levels match or exceed wild type levels in rescue experiments
(Fig. 4C).
Injection of pcdh19 morpholinos results in a severe disruption of
brain morphology, as assessed at 30 hpf (Figs. 4D, E). The hindbrain of
morphant embryos is disorganized and the midbrain–hindbrain
boundary (MHB) is disrupted. In addition, the anterior brain exhibits
ectopic folds of the neural tube, giving the visual impression that it has
buckled and become compressed (Figs. 4D′, E′). Morphants exhibited
a range of phenotypes, which we classiﬁed as mild, moderate or
severe, for the purpose of quantiﬁcation (Supplemental Fig. 3). The
observed phenotypes were dose-dependent (Fig. 5A), and identical
phenotypes were observed in embryos injected with Mo-T, Mo-S1 or
Mo-S2, but not by 5 basepair mismatch control morpholinos (Fig. 5B).
As an additional test of morpholino speciﬁcity, subthreshold doses of
Mo-T and Mo-S1 were found to be additive when co-injected,
indicating that the observed phenotype is due to the interference
with pcdh19 function, not a non-speciﬁc effect of morpholino injection
(Fig. 5B). Finally, we co-injected 200 pg of capped mRNA encoding
full-length pcdh19 with 1.5 ng Mo-T. We found that mRNA injection
attenuated the effects of morpholino injection, as we observed a
reproducible shift toward milder phenotypes (Fig. 5B).
Protocadherin-19 disrupts convergence of the anterior neural plate
As pcdh19 expression begins much earlier in development, we
wanted to determine if the effects of Pcdh19 depletion could be
observed at earlier developmental times. Morphant embryos can
already be clearly identiﬁed at the 10–11 somite stage (Fig. 6). The
brains of wild type embryos at this stage are relatively featureless rods
(Figs. 6A, A′). In contrast, pcdh19morphants appear to have a slightly
shortened body axis, as well as abnormal morphology of the neural
tube and eyes (Figs. 6B, C). Morphant embryos injected with splice-ype is dose-dependent. Using the criteria deﬁned in Supplemental Fig. 3, we ﬁnd that
t morpholinos, including one translation-blocking (Mo-T, 2 ng) and two splice-blocking
h control morpholinos (Mo-S1mis, 4 ng; Mo-Tmis, 4 ng) fail to affect brain morphology.
otype, indicating that the effects of these distinct morpholinos are additive. Finally, co-
ting the distribution of embryos toward milder phenotypes.
Fig. 6. Protocadherin-19 is required for early stages of morphogenesis in the anterior neural plate. A–C, Transmitted light images of live control and morphant embryos at 10–11 somite stage. Disruption of morphogenesis in the head is already
disrupted. A–A″. In control embryos (injected with Mo-S1mis), the brain appears smooth in lateral views (A) and as a featureless rod in dorsal views (A′), as well as in face-on views (A″). The neural rod is highlighted with red shading. In
morphant embryos, the brain is disorganized and the neural rod has the appearance of being misfolded or buckled (B, C) and the optic primordia are often malformed. In dorsal views, the neural rod is very disorganized and is much wider than
control embryos (B′, C′). In face-on views, the neural rod is split, having a Y-shaped appearance (B″, C″). D–G, Shown are cross sections of 4 somite (D, E) and 10 somite (F, G) stage embryos that were labeled with DAPI. At 4 somite stage, the
neural keel is wedge-shaped in the trunk and broader in both the posterior and anterior brain regions. The neural keel is comparable in morphant embryos (E–E″; Mo-S1), although it tends to be somewhat wider. At 10 somite stage, the neural
keel of wild type embryos has converged at all levels along the antero-posterior axis (F–F″). In contrast, the neural keel in morphants (G–G″) has failed to converge in the posterior brain and appears disorganized in the anterior brain, although
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exhibit a malformed neural rod. In both lateral views (Figs. 6B, C) and
dorsal views (Figs. 6B′, C′), the neural rod appears convoluted and
disorganized compared to control embryos (Figs. 6A, A′). When
viewed face-on, the brain has a Y-shaped appearance (Figs. 6B″, C″), as
opposed to a single, linear rod (Fig. 6A″). At the 4 somite stage,
sections through the trunk reveal a wedge-shaped neural keel (Fig.
6D). Corresponding sections through the posterior and anterior brain
(Figs. 6D′ and D″, respectively), exhibit wider cell masses. Sections of
embryos injected with Mo-S1 are comparable to control embryos
(Figs. 6E–E″). By the 10 somite stage, the neural keel of wild type
embryos has converged substantially at all antero-posterior levels
(Figs. 6F–F″). While the neural keel of morphants is comparable to
wild type embryos in the trunk (Fig. 6G), the neural keel at the level of
the hindbrain appears not to have converged between 4 and 10 somite
stages (Fig. 6G′). In addition, although the anterior brain appears to
have converged, in contrast to the posterior brain, it also appears
disorganized (Fig. 6G″). These observations suggest a role for pcdh19
in convergence cell movements during neurulation in the anterior
embryo.
The phenotype of our pcdh19 morphants is reminiscent of ncad
mutants that exhibit a defect in convergence of the lateral neural
plate. To conﬁrm that the effect of abrogating pcdh19 function occurs
late, we labeled embryos with riboprobe against foxd3, which
demarcates the lateral borders of the neural plate (Fig. 7). In control
embryos (Fig. 7A), the neural plate is wide at the 2 somite stage
(Fig. 7A), converges signiﬁcantly between 2 and 5 somite stages, and
continues to convergemore slowly between 5 and 10 somite stages. At
the 2 somite stage, foxd3 staining in pcdh19 morphants is indis-
tinguishable from control embryos (Figs. 7A–C). In contrast, at the 4
somite stage, the neural plate of morphant embryos is much wider
(Figs. 7A′, B′, C′), suggesting an impairment in convergence move-Fig. 7. Impaired of neural plate convergence in pcdh19 morphants. Shown are embryos labe
neural plate. A–C, At 2 somite stage, the width of the neural plate is comparable between co
translation-blocking (C; Mo-T) morpholinos. By the 5 somite stage, the neural plate has conv
This impairment of convergence in morphants becomes even more pronounced by the 10
convergence appears to occur between 5 and 10 somite stages in morphant embryos (B″ anments. Similar results were obtained using riboprobes against pax2.1
and krox20 (Supplemental Fig. 4). This impairment is even more
pronounced when foxd3 stained embryos are compared at the 10
somite stage (Figs. 7A″, B″, C″). These results are similar to those
observed in ncad mutants, which also exhibit an impairment in
convergence of the lateral neural plate.
As early brain development is disrupted in pcdh19 morphants, we
wanted to determine whether regional speciﬁcation of the nervous
system was affected. To do this, we labeled embryos with riboprobes
against pax2.1, which labels the MHB, and krox20, which labels
rhombomeres 3 and 5 (Figs. 8A–C). Abrogation of pcdh19 function
does not appear to affect patterning in the midbrain–hindbrain
region, as pax2.1 and krox20 staining appear normal in morphants
(Figs. 8B, C). Dorsal views conﬁrm the normal axial patterning, as well
as the wider neural keel in morphants (Figs. 8B′, C′) compared to
control embryos (Fig. 8A′). A similar result was obtained with
riboprobe directed against otx2, which labels the prospective optic
tectum (Figs. 8D–F). In addition, we wanted to conﬁrm our earlier
observation (Fig. 6) that convergence movements were unperturbed
in the trunk of pcdh19morphants. Transmitted light images of live 10
somite stage embryos (Figs. 8G–I) reveal that depletion of Pcdh19 has
little effect on somite development and morphogenesis in the trunk
region. Similarly, morphant embryos (8–9 somite stage) labeled with
myod appear normal (Figs. 8J–L).
Our results show the disruption of convergence movements and
neural rodmorphology in embryos depleted of Pcdh19. As the anterior
neural rod appears disorganized in morphants, we wanted to deter-
mine whether the neuroepithelium is intact. To address this, we
performed wholemount immunocytochemistry of 22 hpf embryos
with antibodies against ZO-1, which labels tight junctions at the apical
pole of epithelial cells. In wild type embryos (Fig. 9A), ZO-1 stains the
surface of the neuroepithelium adjacent to the ventricles. Cross-led with riboprobe directed against foxd3, which deﬁnes the lateral boundaries of the
ntrol embryos (A) and morphant embryos injected with splice-blocking (B; Mo-S1) or
erged substantially in control embryos (A′), but is much wider in morphants (B′ and C′).
somite stage. The neural keel narrows somewhat in control embryos (A″), but little
d C″).
Fig. 8. Disruption of pcdh19 function does not alter axial patterning or somitogenesis.
A–C, To assess the effects of pcdh19 depletion on regional speciﬁcation in the brain, we
performed in situ hybridizations on 10 somite stage embryos using riboprobes for
pax2.1, which labels the midbrain–hindbrain boundary, and krox20, which labels
rhombomeres 3 and 5. Compared to control embryos (A), the morphants (B, Mo-S1; C,
Mo-T) exhibited comparable patterns of pax2.1 and krox20 expression, although the
neural plates are substantially wider (compare B′ and C′ with A′). D–F, Similar to what
we observe with pax2.1/krox20, the midbrain region, marked by otx2, appears normal
in morphant embryos. G–I, Transmitted light images of control (G, Mo-S1mis), and
pcdh19 morphant embryos (H, Mo-S1; I, Mo-T). While convergence of the anterior
neural plate appears to be impaired in pcdh19 morphants, convergence in the trunk is
unaffected. J–L, To conﬁrm that morphogenesis in the trunk is normal, 8–9 somite stage
embryos were labeled with riboprobe against myod.
80 M.R. Emond et al. / Developmental Biology 334 (2009) 72–83sectional views through the hindbrain reveal that the opposing faces
of the two sides of the neural tube are parallel, and the apico-basal
axis of the neuroepithelium is aligned with the mediolateral axis
(Fig. 9C). In contrast to wild type embryos, however, much of the
apical surface of the neuroepithelium faces dorsally (Fig. 9B). This can
clearly be seen with cross-sectional views through the hindbrain
(Fig. 9D). These results suggest that the integrity of the neuroepithe-
lium is intact, but has not been properly folded during neurulation.
Our observations suggest that interference with pcdh19 function
results in impaired cell convergence in the anterior neural plate
during development. To demonstrate this more directly, we per-
formed 2-photon timelapse imaging of embryos expressing Histone
H2A-GFP (Tg(h2afz:GFP)kca66; Pauls et al., 2001), which labels nuclei
and provides a high-contrast marker for tracking cell movements.
Wild type and morphant embryos were imaged beginning at the 2
somite stage. We generated maximum intensity projections of 20–25sections (100–125 μm) and used the ﬂuorescence intensity as a
measure of cell density in order to follow cell convergence. In wild
type embryos (n=3), migration of cells toward the dorsal midline
results in the transformation of a nearly isotropic distribution of cells
into a narrow embryonic axis, with the emergence of eye primordia at
the anterior end of the neural tube (Fig. 10A; Supplemental Movie 1).
In contrast, embryos injected with Mo-S1 (n=4) exhibit a failure in
medially-directed cell migration in the anterior neural tube (Fig. 10B;
Supplemental Movie 2). As development proceeds, cells accumulate
laterally to form relatively static ridges. The differences in this collec-
tive cell behavior are presented in kymographs, which illustrate
the changes in the mediolateral cell density as a function of time
(Figs. 10C, D). In contrast to wild type embryos, morphants exhibit a
relatively constant width in the midbrain–hindbrain region over the
duration of the timelapse (Fig. 10D). These results support the
conclusion that convergence cell movements in the anterior neural
plate are arrested in pcdh19 morphants.
Discussion
The ﬁrst step in the morphogenesis of the vertebrate brain is the
formation of the neural tube during neurulation (Copp et al., 2003;
Schoenwolf and Smith, 1990; Schoenwolf and Smith, 2000). In
zebraﬁsh, this occurs through the convergence and infolding of the
neural plate to form the neural keel, then the neural rod (Papan and
Campos-Ortega, 1994; Schmitz et al., 1993). During this process,
medial neural plate cells adopt more ventral positions in the neural
tube, while lateral cells acquire a more dorsal fate. This mapping of
the mediolateral axis onto the ventrodorsal axis requires the rotation
of the apico-basal axis of the neuroepithelium, such that it becomes
coincident with the mediolateral axis of the embryo (Hong and
Brewster, 2006). Here, we have identiﬁed zebraﬁsh pcdh19 and
shown that it is essential for early steps in the morphogenesis of the
brain. It is expressed in the more medial/ventral region of the
anterior neural plate. Depletion of Pcdh19 levels by antisense
morpholino oligonucleotides impairs convergence of the anterior
neural plate, and the subsequent organization of the neural tube is
severely perturbed. The pcdh19 morphants are likely hypomorphs, as
the reduction of Pcdh19, as assessed by RT-PCR, is not complete. A
complete null phenotype must await the isolation of a pcdh19
mutant or targeted disruption using zinc ﬁnger nucleases (Doyon et
al., 2008; Meng et al., 2008).
Convergence cell movements are also affected in ncad and vangl2
mutants. The ncad mutant, parachute, exhibits disorganized and
bumpy brains in 1 dpf embryos, as well as an increased width of the
neural plate in early somitogenesis (Lele et al., 2002). This failure in
convergence has been attributed to reduced motility in the lateral
neural plate, possibly through an effect on lamellipodia dynamics
(Hong and Brewster, 2006). The phenotype we observe in pcdh19
morphants is similar to that of ncad mutants and morphants: late
convergence movements are disrupted in the anterior neural plate,
resulting in a disorganized midbrain–hindbrain region. While the
similarity in the pcdh19 and ncad phenotypes may be due to failure in
a variety of cellular functions to result in a qualitatively similar
outcome (deﬁcient convergence), it could also reﬂect a functional
interaction of these two proteins. For example, Pcdh8/PAPC has been
shown to regulate cell adhesion by C-cadherin during frog gastrula-
tion (Chen and Gumbiner, 2006). Similarly, Pcdh8/PAPC, when
induced in hippocampal neurons by electroconvulsive stimulation,
physically interacts with and induces the internalization of synaptic
N-cadherin (Yasuda et al., 2007). Thus, it is possible that Pcdh19 and
N-cadherin function together during neurulation.
Recently, it was shown that vangl2 mutants exhibit a duplicated
neural tube (Ciruna et al., 2006; Tawk et al., 2007), which was
attributed to delayed convergence in conjunctionwith ectopic mirror-
symmetric C-divisions in the lateral neural plate (Ciruna et al., 2006;
Fig. 9. The neuroepithelium remains intact in pcdh19morphants. Shown are images of 22 hpf embryos immunostained with antibodies against the apical epithelial marker, ZO-1. (A)
Maximum intensity projection of the midbrain–hindbrain region of a wild type embryo (50 sections, spanning 100 μm). ZO-1 labels the apical surface of the neuroepithelium, which
lines the midbrain and hindbrain ventricles. (B) In contrast to the ZO-1 labeling in wild type embryos, much of the apical face of the neuroepithelium in morphant embryos is
oriented dorsally, more parallel to the surface of the embryo. (C) A YZ-plane through the area indicated in A, highlighting that the apical–basal axis of the neuroepithelium is aligned
with the mediolateral axis of the embryo. (D) A YZ-plane through the area indicated in B. In contrast to wild type embryos, much of the apico-basal axis of the neuroepithelium
remains aligned with the dorsoventral axis in morphant embryos.
81M.R. Emond et al. / Developmental Biology 334 (2009) 72–83Tawk et al., 2007). Similar duplications were observed in morphant
embryos that exhibit delayed convergence (Tawk et al., 2007),
including prickle and dishevelled, as well as the gene has2, which has
been shown to affect convergence of mesodermal tissue (Bakkers et
al., 2004). By contrast, we do not observe duplicate neural tubes in
pcdh19 morphants. Immunocytochemistry for ZO-1, which deﬁnesFig. 10. In vivo timelapse imaging reveals an arrest of convergence movements during neuru
transgenic embryos expressing a Histone H2A-GFP fusion protein. Each frame is a maximum
at 3 hour intervals, revealing a net migration of cells toward the midline. By 3 h after the ini
embryo has begun to narrowmediolaterally (blue transparency). Anterior is to the left; scale
have been injected with Mo-S1. In contrast to wild type embryos, cell movement toward the
showing the cell convergence. The increase in ﬂuorescence intensity reﬂects an increase in c
width, shown as a transparent purple bar in A) at each timepoint. (D) A kymograph from t
assembled from a 12 hour timelapse sequence. Movement of cells toward the midline is di
arrows in C and D.the apical surface of the neuroepithelium, only reveals the presence of
a single hindbrain ventricle, rather than the two, symmetric ventricles
present in vangl2 mutants (Tawk et al., 2007). Thus, some aspects of
the pcdh19 morphant phenotype are distinct from those observed in
other mutants and morphants that exhibit impaired convergence cell
movements.lation in pcdh19 morphants. (A) Images extracted from a 6 hour timelapse sequence of
intensity projection of 20 optical sections (spaced at 5 μm). Shown are three timepoints,
tiation of the timelapse, eye primordia have begun to form (red transparency), and the
bar=50 μm. (B) Images extracted from a 12 hour timelapse of transgenic embryos that
midline is arrested. (C) A kymograph from the 6 hour timelapse image sequence in A,
ell density. The kymograph shows the intensity values measured along a line (11 pixel
he timelapse image sequence in B, showing a failure of cell convergence. This data was
srupted in pcdh19 morphants, resulting in a lateral accumulation of cells. Compare red
82 M.R. Emond et al. / Developmental Biology 334 (2009) 72–83While we have shown that Pcdh19 plays an essential role in
neurulation and that depletion of Pcdh19, using morpholinos, results
in an arrest of convergence movements in the anterior neural plate,
several important questions remain to be answered. First, what is the
cellular role played by Pcdh19? As a member of the cadherin
superfamily, it is possible that Pcdh19 acts as an adhesion molecule,
although protocadherins have, thus far, been found to exhibit little or
no adhesive activity (Chen and Gumbiner, 2006; Morishita et al.,
2006). By analogy to Pcdh8/PAPC, it is possible that Pcdh19 could act
as a region-speciﬁc regulator of N-cadherin activity. Alternatively,
several protocadherins have been linked to the actin cytoskeleton
(Nakao et al., 2008) or to regulators of cell migration (Homayouni et
al., 2001; Kohmura et al., 1998; Senzaki et al., 1999), suggesting a role
for protocadherins in cell movements (Aamar and Dawid, 2008;
Murakami et al., 2006). Thus, Pcdh19 may function directly in the
regulation of cell movement during neurulation. Future studies will be
essential for deﬁning the role of Pcdh19 within the cell and relating
this cellular role to developmental events in the embryo.
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